How should we make the admission decision in community-acquired pneumonia? - PubMed (original) (raw)
Review
How should we make the admission decision in community-acquired pneumonia?
D Aronsky et al. Med Clin North Am. 2001 Nov.
Abstract
The spectrum of pneumonia patients ranges from only slightly compromised patients to patients who require life-sustaining measures. Admission decision support algorithms usually are not required for patients at either end of the spectrum. For patients presenting with intermediate severity of illness, decision support algorithms have shown that they can support clinicians in the admission decision and complement the clinicians' experience and clinical judgment with an objective tool. Clinical information systems may help overcome the existing obstacles to successful implementation. Successful guideline implementation in a clinical setting includes strategies that target not only the disease, but also include other forces that significantly influence the admission decision. Shared decision making and better managing of patients' expectations about treatment and prognosis need to be incorporated in the overall admission decision. The availability of improved outpatient management, such as outpatient intravenous antibiotic treatment and home health care, and a change in physicians' perspectives and patients' expectations may help to increase the proportion of outpatient management without compromising the quality of care. Decision support tools for pneumonia are available and show promising results. Further studies are needed, however, that show the successful dissemination and clinical implementation during routine patient care. Studies are needed that assess the impact of guidelines and prediction rules on patient outcomes. As the example of the PSI shows, the development, implementation, and dissemination of admission decision support systems is not a revolutionary, but a stepwise, evolutionary process that requires many years of research.
Similar articles
- Implementation of admission decision support for community-acquired pneumonia.
Dean NC, Suchyta MR, Bateman KA, Aronsky D, Hadlock CJ. Dean NC, et al. Chest. 2000 May;117(5):1368-77. doi: 10.1378/chest.117.5.1368. Chest. 2000. PMID: 10807824 - Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia.
Dean NC. Dean NC. Clin Chest Med. 1999 Sep;20(3):521-9, viii. doi: 10.1016/s0272-5231(05)70233-1. Clin Chest Med. 1999. PMID: 10516901 Review. - Managing CAP: are you up-to-date?
Holten KB, Comte TE. Holten KB, et al. J Fam Pract. 2007 Sep;56(9):720-2. J Fam Pract. 2007. PMID: 17764642 No abstract available. - Community-acquired pneumonia--implementation of a prediction rule to guide selection of patients for outpatient treatment.
Chan SS, Yuen EH, Kew J, Cheung WL, Cocks RA. Chan SS, et al. Eur J Emerg Med. 2001 Dec;8(4):279-86. doi: 10.1097/00063110-200112000-00006. Eur J Emerg Med. 2001. PMID: 11785594 - [Community-acquired pneumonia in children: applications of the WHO decision trees in Switzerland].
Dirlewanger M, Krähenbühl JD, Fanconi S, Vaudaux B, Gehri M. Dirlewanger M, et al. Rev Med Suisse Romande. 2002 Dec;122(12):595-8. Rev Med Suisse Romande. 2002. PMID: 12611183 Review. French. No abstract available.
Cited by
- Severe community-acquired pneumonia.
Sligl WI, Marrie TJ. Sligl WI, et al. Crit Care Clin. 2013 Jul;29(3):563-601. doi: 10.1016/j.ccc.2013.03.009. Crit Care Clin. 2013. PMID: 23830654 Free PMC article. Review. - Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schönenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B; ProHOSP study group. Schuetz P, et al. BMC Health Serv Res. 2007 Jul 5;7:102. doi: 10.1186/1472-6963-7-102. BMC Health Serv Res. 2007. PMID: 17615073 Free PMC article. Clinical Trial. - Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Mandell LA, et al. Clin Infect Dis. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159. Clin Infect Dis. 2007. PMID: 17278083 Free PMC article. No abstract available. - Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B. Christ-Crain M, et al. Crit Care. 2006;10(3):R96. doi: 10.1186/cc4955. Epub 2006 Jun 28. Crit Care. 2006. PMID: 16805922 Free PMC article. Clinical Trial. - Community-acquired pneumonia.
File TM. File TM. Lancet. 2003 Dec 13;362(9400):1991-2001. doi: 10.1016/S0140-6736(03)15021-0. Lancet. 2003. PMID: 14683661 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials